nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—DRD1—attention deficit hyperactivity disorder	0.242	0.315	CbGaD
Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.225	0.292	CbGaD
Thioridazine—DRD2—attention deficit hyperactivity disorder	0.171	0.222	CbGaD
Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.132	0.171	CbGaD
Thioridazine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00676	0.109	CbGeAlD
Thioridazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00421	0.0682	CbGeAlD
Thioridazine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00359	0.0582	CbGeAlD
Thioridazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00224	0.0363	CbGeAlD
Thioridazine—HTR6—forebrain—attention deficit hyperactivity disorder	0.0018	0.0292	CbGeAlD
Thioridazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00134	0.0217	CbGeAlD
Thioridazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00108	0.0175	CbGeAlD
Thioridazine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00104	0.0168	CbGeAlD
Thioridazine—HTR6—nervous system—attention deficit hyperactivity disorder	0.000977	0.0158	CbGeAlD
Thioridazine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000941	0.0152	CbGeAlD
Thioridazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000913	0.0148	CbGeAlD
Thioridazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.000884	0.0143	CbGeAlD
Thioridazine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000876	0.0142	CbGeAlD
Thioridazine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000837	0.0136	CbGeAlD
Thioridazine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000807	0.0131	CbGeAlD
Thioridazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000791	0.0128	CbGeAlD
Thioridazine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.00078	0.0126	CbGeAlD
Thioridazine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00078	0.0126	CbGeAlD
Thioridazine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000751	0.0122	CbGeAlD
Thioridazine—HTR6—brain—attention deficit hyperactivity disorder	0.000747	0.0121	CbGeAlD
Thioridazine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00074	0.012	CbGeAlD
Thioridazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000727	0.0118	CbGeAlD
Thioridazine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000708	0.0115	CbGeAlD
Thioridazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.0007	0.0113	CbGeAlD
Thioridazine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000687	0.0111	CbGeAlD
Thioridazine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000683	0.0111	CbGeAlD
Thioridazine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000659	0.0107	CbGeAlD
Thioridazine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000625	0.0101	CbGeAlD
Thioridazine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000614	0.00994	CbGeAlD
Thioridazine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000596	0.00965	CbGeAlD
Thioridazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000586	0.00949	CbGeAlD
Thioridazine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000578	0.00936	CbGeAlD
Thioridazine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000565	0.00915	CbGeAlD
Thioridazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000564	0.00914	CbGeAlD
Thioridazine—DRD1—brain—attention deficit hyperactivity disorder	0.000556	0.009	CbGeAlD
Thioridazine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000553	0.00895	CbGeAlD
Thioridazine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000544	0.00881	CbGeAlD
Thioridazine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000536	0.00868	CbGeAlD
Thioridazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000522	0.00846	CbGeAlD
Thioridazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000522	0.00845	CbGeAlD
Thioridazine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000515	0.00834	CbGeAlD
Thioridazine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000508	0.00822	CbGeAlD
Thioridazine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000475	0.0077	CbGeAlD
Thioridazine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000475	0.0077	CbGeAlD
Thioridazine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000458	0.00741	CbGeAlD
Thioridazine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000454	0.00736	CbGeAlD
Thioridazine—CHRM2—brain—attention deficit hyperactivity disorder	0.000448	0.00725	CbGeAlD
Thioridazine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000447	0.00724	CbGeAlD
Thioridazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000441	0.00715	CbGeAlD
Thioridazine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000438	0.0071	CbGeAlD
Thioridazine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000437	0.00708	CbGeAlD
Thioridazine—HTR2C—brain—attention deficit hyperactivity disorder	0.000432	0.00699	CbGeAlD
Thioridazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000429	0.00696	CbGeAlD
Thioridazine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000427	0.00692	CbGeAlD
Thioridazine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000423	0.00685	CbGeAlD
Thioridazine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000422	0.00683	CbGeAlD
Thioridazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000414	0.0067	CbGeAlD
Thioridazine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000412	0.00668	CbGeAlD
Thioridazine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000407	0.0066	CbGeAlD
Thioridazine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000405	0.00656	CbGeAlD
Thioridazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000404	0.00655	CbGeAlD
Thioridazine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000398	0.00645	CbGeAlD
Thioridazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000381	0.0471	CrCbGaD
Thioridazine—HTR1A—brain—attention deficit hyperactivity disorder	0.000363	0.00588	CbGeAlD
Thioridazine—HTR7—brain—attention deficit hyperactivity disorder	0.000347	0.00562	CbGeAlD
Thioridazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000345	0.00558	CbGeAlD
Thioridazine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000339	0.00549	CbGeAlD
Thioridazine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000335	0.00542	CbGeAlD
Thioridazine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000333	0.0054	CbGeAlD
Thioridazine—DRD2—brain—attention deficit hyperactivity disorder	0.000328	0.00532	CbGeAlD
Thioridazine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000327	0.00529	CbGeAlD
Thioridazine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000326	0.00528	CbGeAlD
Thioridazine—KCNH2—brain—attention deficit hyperactivity disorder	0.000323	0.00524	CbGeAlD
Thioridazine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000321	0.00519	CbGeAlD
Thioridazine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000314	0.00508	CbGeAlD
Thioridazine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000314	0.00508	CbGeAlD
Thioridazine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000307	0.00497	CbGeAlD
Thioridazine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000296	0.00479	CbGeAlD
Thioridazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000283	0.00459	CbGeAlD
Thioridazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000273	0.00442	CbGeAlD
Thioridazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000267	0.00432	CbGeAlD
Thioridazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000261	0.0322	CrCbGaD
Thioridazine—HRH1—brain—attention deficit hyperactivity disorder	0.000259	0.0042	CbGeAlD
Thioridazine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000258	0.00418	CbGeAlD
Thioridazine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000255	0.00412	CbGeAlD
Thioridazine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000249	0.00403	CbGeAlD
Thioridazine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000248	0.00402	CbGeAlD
Thioridazine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000243	0.00393	CbGeAlD
Thioridazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000233	0.0289	CrCbGaD
Thioridazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.00023	0.0285	CrCbGaD
Thioridazine—Eletriptan—HTR1B—attention deficit hyperactivity disorder	0.000221	0.0274	CrCbGaD
Thioridazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.00022	0.0272	CrCbGaD
Thioridazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000217	0.00351	CbGeAlD
Thioridazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000214	0.0264	CrCbGaD
Thioridazine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000197	0.00319	CbGeAlD
Thioridazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000184	0.0227	CrCbGaD
Thioridazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000178	0.022	CrCbGaD
Thioridazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000165	0.0204	CrCbGaD
Thioridazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.00016	0.0198	CrCbGaD
Thioridazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.0189	CrCbGaD
Thioridazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000148	0.0183	CrCbGaD
Thioridazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000145	0.0179	CrCbGaD
Thioridazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000143	0.0177	CrCbGaD
Thioridazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000142	0.0176	CrCbGaD
Thioridazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000142	0.0176	CrCbGaD
Thioridazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.00014	0.0173	CrCbGaD
Thioridazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000138	0.0171	CrCbGaD
Thioridazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000132	0.0163	CrCbGaD
Thioridazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000125	0.0155	CrCbGaD
Thioridazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000125	0.0155	CrCbGaD
Thioridazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000123	0.0152	CrCbGaD
Thioridazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000119	0.0148	CrCbGaD
Thioridazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000118	0.0146	CrCbGaD
Thioridazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000116	0.0144	CrCbGaD
Thioridazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.0141	CrCbGaD
Thioridazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000113	0.0139	CrCbGaD
Thioridazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000104	0.0129	CrCbGaD
Thioridazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000104	0.0129	CrCbGaD
Thioridazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000103	0.0128	CrCbGaD
Thioridazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000103	0.0127	CrCbGaD
Thioridazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000102	0.0126	CrCbGaD
Thioridazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000101	0.0125	CrCbGaD
Thioridazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.0001	0.0124	CrCbGaD
Thioridazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	0.0001	0.0124	CrCbGaD
Thioridazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	9.89e-05	0.0122	CrCbGaD
Thioridazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	9.72e-05	0.012	CrCbGaD
Thioridazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	9.58e-05	0.0118	CrCbGaD
Thioridazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	9.39e-05	0.0116	CrCbGaD
Thioridazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	9.11e-05	0.0113	CrCbGaD
Thioridazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	9.03e-05	0.0112	CrCbGaD
Thioridazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	8.99e-05	0.0111	CrCbGaD
Thioridazine—Promazine—DRD1—attention deficit hyperactivity disorder	8.76e-05	0.0108	CrCbGaD
Thioridazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	8.66e-05	0.0107	CrCbGaD
Thioridazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	8.33e-05	0.0103	CrCbGaD
Thioridazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	8.14e-05	0.0101	CrCbGaD
Thioridazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	8.06e-05	0.00996	CrCbGaD
Thioridazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	7.97e-05	0.00985	CrCbGaD
Thioridazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	7.87e-05	0.00973	CrCbGaD
Thioridazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	7.85e-05	0.00971	CrCbGaD
Thioridazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	7.75e-05	0.00958	CrCbGaD
Thioridazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	7.75e-05	0.00958	CrCbGaD
Thioridazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	7.71e-05	0.00953	CrCbGaD
Thioridazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	7.65e-05	0.00945	CrCbGaD
Thioridazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	7.16e-05	0.00886	CrCbGaD
Thioridazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	7.13e-05	0.00881	CrCbGaD
Thioridazine—Promethazine—DRD2—attention deficit hyperactivity disorder	7.02e-05	0.00868	CrCbGaD
Thioridazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	6.93e-05	0.00856	CrCbGaD
Thioridazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.85e-05	0.00847	CrCbGaD
Thioridazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	6.69e-05	0.00828	CrCbGaD
Thioridazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	6.44e-05	0.00796	CrCbGaD
Thioridazine—Promazine—DRD2—attention deficit hyperactivity disorder	6.18e-05	0.00763	CrCbGaD
Thioridazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	6.12e-05	0.00757	CrCbGaD
Thioridazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	5.51e-05	0.00681	CrCbGaD
Thioridazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	5.44e-05	0.00672	CrCbGaD
Thioridazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	5.42e-05	0.00671	CrCbGaD
Thioridazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	5.35e-05	0.00662	CrCbGaD
Thioridazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	5.29e-05	0.00654	CrCbGaD
Thioridazine—Promazine—HTR2A—attention deficit hyperactivity disorder	4.77e-05	0.0059	CrCbGaD
Thioridazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	4.2e-05	0.00519	CrCbGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.95e-05	0.000121	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.94e-05	0.000121	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.94e-05	0.000121	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.93e-05	0.00012	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.91e-05	0.000119	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000119	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.9e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.9e-05	0.000118	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.9e-05	0.000118	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.89e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000117	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.87e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.87e-05	0.000116	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.86e-05	0.000116	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000115	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000115	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.84e-05	0.000114	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.84e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.83e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000113	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.82e-05	0.000113	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.81e-05	0.000113	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000113	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.8e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.8e-05	0.000112	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.79e-05	0.000111	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.79e-05	0.000111	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.78e-05	0.000111	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.78e-05	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.78e-05	0.000111	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.77e-05	0.00011	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.77e-05	0.00011	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.77e-05	0.00011	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.00011	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.76e-05	0.000109	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000109	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.75e-05	0.000109	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.74e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.73e-05	0.000108	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.73e-05	0.000108	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.000108	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.71e-05	0.000106	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.71e-05	0.000106	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.68e-05	0.000105	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.68e-05	0.000104	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.65e-05	0.000103	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000103	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.65e-05	0.000103	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000102	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000102	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.63e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.63e-05	0.000101	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.62e-05	0.0001	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.61e-05	0.0001	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.61e-05	9.99e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.61e-05	9.99e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.58e-05	9.83e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.57e-05	9.78e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.55e-05	9.65e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.55e-05	9.64e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.52e-05	9.45e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.52e-05	9.44e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.51e-05	9.39e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.51e-05	9.39e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.51e-05	9.36e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.5e-05	9.31e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.49e-05	9.24e-05	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.47e-05	9.14e-05	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.46e-05	9.09e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.45e-05	9e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.43e-05	8.87e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	8.84e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.41e-05	8.79e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.4e-05	8.74e-05	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.4e-05	8.7e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.39e-05	8.63e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.39e-05	8.63e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.39e-05	8.63e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.38e-05	8.59e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.38e-05	8.59e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.37e-05	8.55e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.37e-05	8.49e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.36e-05	8.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.36e-05	8.48e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.34e-05	8.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.34e-05	8.32e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.33e-05	8.3e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.33e-05	8.25e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.32e-05	8.18e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.31e-05	8.14e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.29e-05	8.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.28e-05	7.99e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.28e-05	7.95e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.27e-05	7.9e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.27e-05	7.89e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.27e-05	7.88e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.25e-05	7.75e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.24e-05	7.74e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.24e-05	7.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.24e-05	7.73e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.24e-05	7.7e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.22e-05	7.61e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	7.61e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	7.57e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.21e-05	7.55e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.21e-05	7.51e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.21e-05	7.51e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.21e-05	7.51e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.2e-05	7.47e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	1.2e-05	7.46e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.2e-05	7.46e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.19e-05	7.42e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.19e-05	7.41e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.18e-05	7.37e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	1.18e-05	7.34e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.17e-05	7.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.17e-05	7.28e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.17e-05	7.27e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	7.24e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.18e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.15e-05	7.15e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.15e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.04e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.02e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.13e-05	7.01e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	7e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	6.96e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.11e-05	6.9e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.11e-05	6.9e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.11e-05	6.89e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.1e-05	6.82e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.09e-05	6.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.09e-05	6.78e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.09e-05	6.76e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.09e-05	6.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.07e-05	6.68e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.07e-05	6.68e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.07e-05	6.67e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.07e-05	6.66e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.07e-05	6.66e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.07e-05	6.66e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.62e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.61e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.06e-05	6.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.06e-05	6.57e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.06e-05	6.56e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	6.56e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.05e-05	6.56e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.05e-05	6.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	6.55e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.52e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.04e-05	6.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.04e-05	6.48e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.45e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	6.43e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.35e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.28e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	9.84e-06	6.12e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.84e-06	6.12e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.78e-06	6.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.78e-06	6.08e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	9.75e-06	6.07e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.75e-06	6.07e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.72e-06	6.05e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.7e-06	6.03e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	9.68e-06	6.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	9.68e-06	6.02e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	9.6e-06	5.97e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.58e-06	5.96e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.54e-06	5.94e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.51e-06	5.92e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.49e-06	5.9e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.16e-06	5.7e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	9.15e-06	5.69e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.12e-06	5.67e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	9.08e-06	5.65e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9e-06	5.6e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.92e-06	5.55e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.84e-06	5.5e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.55e-06	5.32e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	8.4e-06	5.23e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.34e-06	5.19e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.34e-06	5.19e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.34e-06	5.19e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.2e-06	5.1e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.14e-06	5.06e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.88e-06	4.9e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.87e-06	4.89e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.84e-06	4.88e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.8e-06	4.85e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.62e-06	4.74e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.5e-06	4.67e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.49e-06	4.66e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.42e-06	4.62e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	7.26e-06	4.52e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	7.21e-06	4.49e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.99e-06	4.35e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.92e-06	4.3e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.79e-06	4.23e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.68e-06	4.16e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.66e-06	4.15e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.66e-06	4.15e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	6.48e-06	4.03e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	6.44e-06	4e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.34e-06	3.95e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.24e-06	3.88e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.19e-06	3.85e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.96e-06	3.71e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.92e-06	3.68e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	5.91e-06	3.68e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	5.87e-06	3.65e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.69e-06	3.54e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.64e-06	3.51e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.63e-06	3.5e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.05e-06	3.14e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.01e-06	3.12e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.86e-06	3.03e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.85e-06	3.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.17e-06	2.6e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.15e-06	2.58e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.97e-06	2.47e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	3.92e-06	2.44e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.66e-06	2.28e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.61e-06	2.24e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.6e-06	2.24e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.6e-06	2.24e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.54e-06	2.2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.53e-06	2.2e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.28e-06	2.04e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.11e-06	1.94e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.78e-06	1.73e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.56e-06	1.59e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.17e-06	1.35e-05	CbGpPWpGaD
